Monitoring the mind: How tech can prevent seizures
Now, leading-edge software and one of the nation's largest neurological monitoring teams at Aurora Health Care can intervene at a moment's notice to prevent prolonged seizures and the health issues that accompany them.
Located at Aurora's Heil Center, adjacent to Aurora St. Luke's Medical Center in Milwaukee, banks of monitors and telemetry allow technologists to simultaneously observe 64 patients undergoing continuous electroencephalogram (cEEG) testing across hospitals in Wisconsin and Illinois. Aurora Health Care is part of Advocate Health, the nation's third-largest nonprofit health care system.
expand
A seizure is a sudden burst of electrical activity in the brain. It can cause changes in behavior, movements, feelings and levels of consciousness. There are many types of seizures with a range of symptoms and vary in how much they affect daily life. Seizure types also vary by where they begin in the brain and how far they spread. Most seizures last from 30 seconds to two minutes. A seizure that lasts longer than five minutes is a medical emergency.
Nearly 4 million American adults and children live with active epilepsy, which is a neurological disease characterized by recurrent seizures. But epilepsy doesn't cause all seizures. Seizures can result from a stroke, head trauma, tumor, or a family history of the condition.
'A seizure can occur as a symptom of a health condition, such as a metabolic problem like low magnesium or a side effect of a medication,' says Dr. Ikram Khan, a neurologist at Aurora Health Care. 'Unlike epilepsy, treating the health condition causing the seizures will cause the seizures to subside.'
EEG tests are used to detect the electrical activity and any abnormalities in brain waves and help diagnose epilepsy and the potential causes of seizures. Electrodes placed on a patient's head can detect tiny electrical discharges that result from the activity of your brain cells and shows how well different areas of the brain are working.
Aurora Health Care's continuous EEG monitoring allows patient brain activity to be monitored for longer durations than the standard EEG. The room is staffed 24/7 by neurodiagnostic monitoring teammates with oversight from lead neurodiagnostic technicians who identify epileptic activity and transmit information directly to the patient's care team.
expand
This system also utilizes intercom, enabling technicians in the monitoring room to speak directly with providers and seizure patients at each of Advocate Health's 28 hospitals in Wisconsin and Illinois. This key feature provides crucial data to patient care teams and enables real-time analysis.
Through this advanced software, Aurora's neurodiagnostic teams are able to offer the community faster, life-saving epilepsy treatment, shorter hospital stays and a quicker return home and a healthy way of life.
'Aurora's epilepsy monitoring technology expansion unites each of its neurodiagnostic departments with electroencephalogram (EEG) monitoring services, seamlessly coordinating care, improving patient outcomes and enabling faster pharmacological intervention when needed,' said Steven Winkelmeyer, director of neurodiagnostic services.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
an hour ago
State Department stopping issuance of visitor visas for 'individuals from Gaza'
The U.S. State Department has announced that it's suspending the issuance of all visitor visas for people from the war-torn Gaza Strip, including children in need of urgent medical care. "All visitor visas for individuals from Gaza are being stopped while we conduct a full and thorough review of the process and procedures used to issue a small number of temporary medical-humanitarian visas in recent days," the State Department wrote in a post on X on Saturday. Based on State Department statistics from January 2025 through the end of May 2025, a total of 3,804 class B1/B2 visas have been issued for individuals with Palestinian Authority travel documents. While the State Department numbers do not specify the purpose of the trips nor how many of the 3,804 visas issued were class B1 or B2, individuals seeking to enter the United States for tourism or medical treatment fall under the B2 visa class, while B1 visas cover business travel. An ABC News request for comment sent to the State Department did not immediately receive a response. Describing one of the latest transfers of Palestinians seeking treatment in the U.S., HEAL Palestine, an American nonprofit organization, announced that 11 severely injured Palestinian children, along with 26 accompanying family members, successfully crossed from Gaza into Jordan on July 30, 2025, in coordination from the World Health Organization and were planning to enter the U.S. in August. "Many of the children suffer from critical injuries such as amputations, severe burns, and trauma-related complications – conditions that Gaza's collapsed health system can no longer treat," according to HEAL Palestine.
6 hours ago
Draft of new 'MAHA' report suggests RFK Jr. won't target pesticides
The draft of an upcoming government report suggesting ways to improve the health of American children does not recommend severe restrictions on pesticides and ultra-processed foods, according to a copy of the document obtained by ABC News. The draft's language, if left unchanged, would constitute a win for the agriculture industry and a potential setback for Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and his "Make America Healthy Again" (MAHA) allies, who have railed against the use of chemical additives in America's food supply, arguing that they harm children. A person familiar with the draft cautioned that the language could still change before it's released to the public. "Unless officially released by the administration, any document purporting to be the MAHA report should be dismissed as speculative literature," White House deputy press secretary Kush Desai said in response to ABC News' request for comment. An HHS spokesperson declined to verify the document's authenticity. The New York Times first reported details of the new draft report. The report will be the second "MAHA" report released by the Trump administration following one published in May. Both were composed by officials in the White House and across different federal agencies, including Kennedy's HHS. The May report detailed the factors officials said were worsening the health of American children and called for a second report, within 100 days, to recommend policies to address those factors. The earlier report -- which was dogged by the revelation that some studies it cited were nonexistent -- cited damning statistics about the effect of chemical food additives, tying them to cancer and developmental disorders. The draft of the new report does not signal any intention to eliminate pesticides from America's food. Instead, the draft calls for "more targeted and precise pesticide applications" and research programs that would "help to decrease pesticide volumes." The report also stated the Environmental Protection Agency "will work to ensure that the public has awareness and confidence in EPA's robust pesticide review procedures and how that relates to the limiting of risk for users and the general public." Regarding ultra-processed foods, the new report states only that HHS, the U.S. Department of Agriculture and the Food and Drug Administration would work to develop a "government-wide definition for 'ultra-processed food.'" In his January confirmation hearing, Kennedy declared that "something is poisoning the American people, and we know that the primary culprits are changing food supply, a switch to highly chemical intensive processed foods." Meanwhile, some "MAHA" influencers have loudly demanded changes to the country's food supply, putting their faith in Kennedy to leverage his position of power to uproot the agriculture industry. But this summer, agriculture groups lobbied intensely against the inclusion of anti-pesticide recommendations in the new report. They appeared to find an ally in Secretary of Agriculture Brooke Rollins, who indicated to reporters this month that the upcoming report would spare pesticides. "There is no chance that our current system of agriculture can survive without those crop protection tools," she said at a press conference in a Washington. "I feel very confident that his, and our, commitment to make sure that farmers are at the table remains paramount, and that the report will reflect that."
Yahoo
10 hours ago
- Yahoo
Elevance Health (NYSE:ELV) Is Reinvesting At Lower Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Having said that, from a first glance at Elevance Health (NYSE:ELV) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. What Is Return On Capital Employed (ROCE)? For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Elevance Health, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.11 = US$8.7b ÷ (US$122b - US$44b) (Based on the trailing twelve months to June 2025). So, Elevance Health has an ROCE of 11%. By itself that's a normal return on capital and it's in line with the industry's average returns of 11%. See our latest analysis for Elevance Health In the above chart we have measured Elevance Health's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Elevance Health for free. What Does the ROCE Trend For Elevance Health Tell Us? In terms of Elevance Health's historical ROCE movements, the trend isn't fantastic. Around five years ago the returns on capital were 14%, but since then they've fallen to 11%. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run. The Bottom Line While returns have fallen for Elevance Health in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. These trends are starting to be recognized by investors since the stock has delivered a 16% gain to shareholders who've held over the last five years. Therefore we'd recommend looking further into this stock to confirm if it has the makings of a good investment. Elevance Health could be trading at an attractive price in other respects, so you might find our on our platform quite valuable. For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
